# DUSP18

## Overview
DUSP18 is a gene that encodes the protein dual specificity phosphatase 18, which is a member of the atypical dual-specificity phosphatase (DSP) subgroup. This protein is characterized by its ability to dephosphorylate both tyrosine and serine/threonine residues, playing a crucial role in modulating mitogen-activated protein kinase (MAPK) signaling pathways. These pathways are integral to various cellular processes, including proliferation, differentiation, and stress responses (Wu2003Molecular). DUSP18 is localized primarily in the mitochondria, where it functions as a peripheral membrane protein associated with the inner mitochondrial membrane (Rardin2008Dual). The protein's unique structural features, including a distinct C-terminal motif, suggest specialized substrate recognition capabilities (Rardin2008Dual). DUSP18 is expressed in multiple human tissues, indicating its involvement in maintaining cellular homeostasis across different organ systems (Wu2003Molecular). Its interactions with proteins such as ataxin-1 and USF1 highlight its potential roles in neurodegenerative diseases and cancer, respectively, making it a significant target for therapeutic research (Zhou2024Inhibition; Ryu2018Dualspecificity).

## Structure
DUSP18 encodes a 188-amino acid protein with a predicted molecular mass of 21.04 kDa and an isoelectric point of 7.24 (Wu2003Molecular). The protein contains a dual-specificity phosphatase (DSP) domain spanning residues 19 to 157, which is characteristic of the DSP protein family (Wu2003Molecular). This domain includes the active motif (H/V)CX5R(S/T) and key residues such as Asp-73, Cys-104, and Ser-111, which are crucial for its phosphatase activity (Wu2003Molecular). Unlike most DSPs, DUSP18 lacks the cdc25 homology domain (CH2), which is typically conserved in the N-terminal region of DSPs (Wu2003Molecular).

DUSP18 is classified as a class I cysteine-based phosphatase within the atypical DSP subgroup (Rardin2008Dual). The protein is localized to the mitochondria, specifically targeting the inner mitochondrial membrane, and is associated with the intermembrane space as a peripheral membrane protein (Rardin2008Dual). The crystal structure of human DSP18 reveals a unique C-terminal motif not seen in any known protein tyrosine phosphatase (PTP) structure, suggesting a unique region for substrate recognition (Rardin2008Dual). The protein's structure and localization are critical for its function in dephosphorylating specific substrates, including MAPKs (Jeong2014The).

## Function
DUSP18 (dual specificity phosphatase 18) is a phosphatase enzyme that plays a significant role in regulating cellular processes by dephosphorylating both tyrosine and serine/threonine residues. This activity is crucial for modulating MAP kinase signaling pathways, which are involved in various cellular functions such as proliferation, differentiation, and stress responses (Wu2003Molecular). DUSP18 is primarily active in the cytoplasm, where it influences cell cycle progression and apoptosis, contributing to cellular homeostasis and organismal development (Wu2003Molecular).

In healthy human cells, DUSP18 is expressed in multiple tissues, including the liver, brain, ovary, and testis, with lower expression levels in other tissues, suggesting a role in maintaining basic cellular functions across different organ systems (Wu2003Molecular). The enzyme's activity is optimal at pH 6.0 and 55°C, and it is enhanced by Mn2+ ions, indicating specific conditions under which it functions most effectively (Wu2003Molecular).

DUSP18 also interacts with proteins such as ataxin-1, modulating their sumoylation and aggregation, which is relevant in the context of neurodegenerative diseases. This interaction suggests a potential role in mitigating stress responses and maintaining protein homeostasis in cells (Ryu2018Dualspecificity).

## Clinical Significance
DUSP18 has been implicated in colorectal cancer (CRC) due to its role in modulating tumor immunity and cholesterol biosynthesis. Overexpression of DUSP18 is associated with immune deserts in CRC, characterized by poor CD8+ T cell infiltration and increased T cell exhaustion, leading to an immunosuppressive tumor microenvironment. This overexpression correlates with advanced clinical stages and poor patient survival (Zhou2024Inhibition). DUSP18's regulatory effect on the USF1 transcription factor and subsequent activation of SREBF2 results in lanosterol accumulation, which suppresses CD8+ T cell-mediated antitumor immunity (Zhou2024Inhibition). 

Inhibition of DUSP18 has been shown to enhance CD8+ T cell function and infiltration, suggesting its potential as a therapeutic target to boost anti-tumor immunity in CRC (Zhou2024Inhibition). The gene's expression is also linked to cholesterol biosynthesis pathways, with its inhibition impairing cholesterol production and enhancing immune responses (Zhou2024Inhibition). These findings highlight the clinical significance of DUSP18 in CRC, where its expression levels could serve as biomarkers for personalizing treatment strategies (Zhou2024Inhibition).

## Interactions
DUSP18 interacts with several proteins, influencing various cellular processes. It is known to interact with ataxin-1, a protein associated with neurodegenerative diseases. DUSP18 modulates the SUMOylation and aggregation of ataxin-1, particularly affecting polyQ-expanded ataxin-1 by decreasing the formation of large aggregates without altering its steady-state level. This interaction is linked to the downregulation of SUMOylation, as demonstrated by the inability of a C104S mutant to reduce aggregation (Ryu2018Dualspecificity). DUSP18 also interacts with the Sp100 protein, a component of promyelocytic leukemia (PML) nuclear bodies, disrupting its interaction with ataxin-1 by inhibiting SUMOylation, which leads to the redistribution of Sp100 (Ryu2018Dualspecificity).

In colorectal cancer, DUSP18 interacts with the transcription factor USF1, regulating the expression of SREBF2, which is involved in cholesterol biosynthesis. This interaction stabilizes USF1 by dephosphorylating it at specific threonine residues, crucial for USF1's stability and its ability to activate SREBF2 transcription (Zhou2024Inhibition). The interaction between DUSP18 and USF1 is significant in the context of tumor immune evasion, as it affects cholesterol biosynthesis and immune response (Zhou2024Inhibition).


## References


[1. (Zhou2024Inhibition) Xiaojun Zhou, Genxin Wang, Chenhui Tian, Lin Du, Edward V. Prochownik, and Youjun Li. Inhibition of dusp18 impairs cholesterol biosynthesis and promotes anti-tumor immunity in colorectal cancer. Nature Communications, July 2024. URL: http://dx.doi.org/10.1038/s41467-024-50138-x, doi:10.1038/s41467-024-50138-x. This article has 1 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-024-50138-x)

[2. (Rardin2008Dual) Matthew J. Rardin, Sandra E. Wiley, Anne N. Murphy, David J. Pagliarini, and Jack E. Dixon. Dual specificity phosphatases 18 and 21 target to opposing sides of the mitochondrial inner membrane. Journal of Biological Chemistry, 283(22):15440–15450, May 2008. URL: http://dx.doi.org/10.1074/jbc.m709547200, doi:10.1074/jbc.m709547200. This article has 23 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m709547200)

[3. (Jeong2014The) Dae Gwin Jeong, Chun Hua Wei, Bonsu Ku, Tae Jin Jeon, Pham Ngoc Chien, Jae Kwan Kim, So Ya Park, Hyun Sook Hwang, Sun Young Ryu, Hwangseo Park, Deok-Soo Kim, Seung Jun Kim, and Seong Eon Ryu. The family-wide structure and function of human dual-specificity protein phosphatases. Acta Crystallographica Section D Biological Crystallography, 70(2):421–435, January 2014. URL: http://dx.doi.org/10.1107/s1399004713029866, doi:10.1107/s1399004713029866. This article has 36 citations.](https://doi.org/10.1107/s1399004713029866)

[4. (Wu2003Molecular) Qihan Wu, Shaohua Gu, Jianliang Dai, Jianfeng Dai, Liu Wang, Yao Li, Li Zeng, Jian Xu, Xin Ye, Wei Zhao, Chaoneng Ji, Yi Xie, and Yumin Mao. Molecular cloning and characterization of a novel dual-specificity phosphatase18 gene from human fetal brain. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1625(3):296–304, February 2003. URL: http://dx.doi.org/10.1016/s0167-4781(02)00629-2, doi:10.1016/s0167-4781(02)00629-2. This article has 9 citations.](https://doi.org/10.1016/s0167-4781(02)00629-2)

[5. (Ryu2018Dualspecificity) Joohyun Ryu and Do Hee Lee. Dual-specificity phosphatase 18 modulates the sumoylation and aggregation of ataxin-1. Biochemical and Biophysical Research Communications, 502(3):389–396, July 2018. URL: http://dx.doi.org/10.1016/j.bbrc.2018.05.178, doi:10.1016/j.bbrc.2018.05.178. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.bbrc.2018.05.178)